IgE-dependent mast cell activation potentiates airway responses in murine asthma models

Journal of Immunology

Volumn 169, Issue 4, 2002, Pages 2061-2068

  Mayr, Susanne I ^a   Zuberi, Riaz I ^a   Zhang, Min ^a   De Sousa Hitzler, Jean ^a   Ngo, Karen ^a   Kuwabara, Yasuko ^a   Yu, Lan ^a   Fung Leung, Wai Ping ^a   Liu, Fu Tong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL DIFFERENTIATION; CONTROLLED STUDY; CROSS LINKING; ENVIRONMENTAL EXPOSURE; GENE DELETION; IMMUNE RESPONSE; INFLAMMATORY CELL; LUNG ALVEOLUS EPITHELIUM; MAST CELL; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM;

EID: 0037103162     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.4.2061     Document Type: Article

References (48)

1. The pathobiology of bronchial asthma
2. Immunologic basis of antigen-induced airway hyperresponsiveness
3. T cells and eosinophils in the pathogenesis of asthma
4. The role of allergy in the development of asthma
5. The mast cell
6. Mast-cell-leukocyte cytokine cascades in allergic inflammation
7. + cells produce Th2 cytokines concomitant with airway eosinophilia and hyperresponsiveness
8. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FcεRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells
9. Mast cell activation enhances airway responsiveness to methacholine in the mouse
10. Mast cells modulate allergic pulmonary eosinophilia in mice
11. + T cells and supplemental role of mast cells in allergic pulmonary eosinophilia
12. Experimental pulmonary eosinophilia in mice by Ascaris suum extract
13. Attenuation of allergic airway inflammation in IL-4 deficient mice
14. Role of mast cells, eosinophils and IL-5 in the development of airway hyperresponsiveness in sensitized mice
15. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice
16. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice
17. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model
18. Reducing IgE levels as a strategy for the treatment of asthma
19. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis
20. Treatment of allergic asthma with monoclonal anti-IgE antibody
21. Anti-IgE therapy for asthma
22. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma
23. Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness
24. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice
25. Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness: A murine model
26. mRNA variants encoding multiple forms of the high-affinity IgE receptor a subunit in transformed and nontransformed mast cells
27. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression
28. The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent
29. Monoclonal dinitrophenyl-specific murine IgE antibody: Preparation, isolation, and characterization
30. Regulation of mast cell survival by IgE
31. The relative contributions of extracellular and intracellular calcium to secretion from tumor mast cells: Multiple effects of the proton ionophore carbonyl cyanide m-chlorophenylhydrazone
32. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent: Partial inhibition of the reaction with antiserum against tumor necrosis factor-α
33. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography
34. The receptor with high affinity for IgE
35. The high-affinity IgE receptor (FcεRI): From physiology to pathology
36. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene
37. Systemic anaphylaxis in the mouse can be mediated largely through IgGI and FcγRIII: Assessment of the cardiopulmonary changes, mast cell degranulafion, and death associated with active or IgE- or IgGI-dependent passive anaphylaxis
38. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness
39. Role for IgE in airway secretions: IgE immune complexes are more potent inducers than antigen alone of airway inflammation in a murine model
40. Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge
41. Complexity and redundancy in the pathogenesis of asthma: Reassessing the roles of mast cells and T cells
42. Mast cell-T cell interactions
43. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
44. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
45. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5
46. Peripheral blood dendritic cells express FcεRI as a complex composed of FcεRI α- and FcεRI γ-chains and can use this receptor for IgE-mediated allergen presentation
47. The high affinity IgE receptor (FcεRI) mediates IgE-dependent allergen presentation
48. FcεRI-mediated antigen endocytosis turns interferon-γ-treated mouse mast cells from inefficient into potent antigen-presenting cells